These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 30550624)

  • 1. Detection of malignancy-associated phosphoproteome changes in human colorectal cancer induced by cell surface binding of growth-inhibitory galectin-4.
    Michalak M; Warnken U; Schnölzer M; Gabius HJ; Kopitz J
    IUBMB Life; 2019 Mar; 71(3):364-375. PubMed ID: 30550624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of Proteome Changes in Human Colon Cancer Induced by Cell Surface Binding of Growth-Inhibitory Human Galectin-4 Using Quantitative SILAC-Based Proteomics.
    Michalak M; Warnken U; André S; Schnölzer M; Gabius HJ; Kopitz J
    J Proteome Res; 2016 Dec; 15(12):4412-4422. PubMed ID: 27801591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The glutamine transporter ASCT2 (SLC1A5) promotes tumor growth independently of the amino acid transporter LAT1 (SLC7A5).
    Cormerais Y; Massard PA; Vucetic M; Giuliano S; Tambutté E; Durivault J; Vial V; Endou H; Wempe MF; Parks SK; Pouyssegur J
    J Biol Chem; 2018 Feb; 293(8):2877-2887. PubMed ID: 29326164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutamine addiction activates polyglutamine-based nanocarriers delivering therapeutic siRNAs to orthotopic lung tumor mediated by glutamine transporter SLC1A5.
    Wang C; Wu J; Wang Z; Yang Z; Li Z; Deng H; Li L; Peng X; Feng M
    Biomaterials; 2018 Nov; 183():77-92. PubMed ID: 30149232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deciphering the galectin-12 protein interactome reveals a major impact of galectin-12 on glutamine anaplerosis in colon cancer cells.
    Katzenmaier EM; Fuchs V; Warnken U; Schnölzer M; Gebert J; Kopitz J
    Exp Cell Res; 2019 Jun; 379(2):129-139. PubMed ID: 30935948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Role of ASCT2 (SLC1A5) in KRAS-Mutated Colorectal Cancer.
    Toda K; Nishikawa G; Iwamoto M; Itatani Y; Takahashi R; Sakai Y; Kawada K
    Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28749408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative phosphoproteomics of cytotoxic T cells to reveal protein kinase d 2 regulated networks.
    Navarro MN; Goebel J; Hukelmann JL; Cantrell DA
    Mol Cell Proteomics; 2014 Dec; 13(12):3544-57. PubMed ID: 25266776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative proteome and phosphoproteome analyses of cultured cells based on SILAC labeling without requirement of serum dialysis.
    Imami K; Sugiyama N; Tomita M; Ishihama Y
    Mol Biosyst; 2010 Mar; 6(3):594-602. PubMed ID: 20174688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SLC1A5 Silencing Inhibits Esophageal Cancer Growth via Cell Cycle Arrest and Apoptosis.
    Lin J; Yang T; Peng Z; Xiao H; Jiang N; Zhang L; Ca D; Wu P; Pan Q
    Cell Physiol Biochem; 2018; 48(1):397. PubMed ID: 30071532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global dynamics of the Escherichia coli proteome and phosphoproteome during growth in minimal medium.
    Soares NC; Spät P; Krug K; Macek B
    J Proteome Res; 2013 Jun; 12(6):2611-21. PubMed ID: 23590516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topotecan induces apoptosis via ASCT2 mediated oxidative stress in gastric cancer.
    Wang L; Liu Y; Zhao TL; Li ZZ; He JY; Zhang BJ; Du HZ; Jiang JW; Yuan ST; Sun L
    Phytomedicine; 2019 Apr; 57():117-128. PubMed ID: 30668314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ATF4 Deficiency Promotes Intestinal Inflammation in Mice by Reducing Uptake of Glutamine and Expression of Antimicrobial Peptides.
    Hu X; Deng J; Yu T; Chen S; Ge Y; Zhou Z; Guo Y; Ying H; Zhai Q; Chen Y; Yuan F; Niu Y; Shu W; Chen H; Ma C; Liu Z; Guo F
    Gastroenterology; 2019 Mar; 156(4):1098-1111. PubMed ID: 30452920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1,25-Dihydroxyvitamin D inhibits glutamine metabolism in Harvey-ras transformed MCF10A human breast epithelial cell.
    Zhou X; Zheng W; Nagana Gowda GA; Raftery D; Donkin SS; Bequette B; Teegarden D
    J Steroid Biochem Mol Biol; 2016 Oct; 163():147-56. PubMed ID: 27154413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting of glutamine transporter ASCT2 and glutamine synthetase suppresses gastric cancer cell growth.
    Ye J; Huang Q; Xu J; Huang J; Wang J; Zhong W; Chen W; Lin X; Lin X
    J Cancer Res Clin Oncol; 2018 May; 144(5):821-833. PubMed ID: 29435734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative Phosphoproteomics Revealed Glucose-Stimulated Responses of Islet Associated with Insulin Secretion.
    Li J; Li Q; Tang J; Xia F; Wu J; Zeng R
    J Proteome Res; 2015 Nov; 14(11):4635-46. PubMed ID: 26437020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Centromere protein F (CENPF), a microtubule binding protein, modulates cancer metabolism by regulating pyruvate kinase M2 phosphorylation signaling.
    Shahid M; Lee MY; Piplani H; Andres AM; Zhou B; Yeon A; Kim M; Kim HL; Kim J
    Cell Cycle; 2018; 17(24):2802-2818. PubMed ID: 30526248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cys Site-Directed Mutagenesis of the Human SLC1A5 (ASCT2) Transporter: Structure/Function Relationships and Crucial Role of Cys467 for Redox Sensing and Glutamine Transport.
    Scalise M; Pochini L; Console L; Pappacoda G; Pingitore P; Hedfalk K; Indiveri C
    Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ASCT2/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer.
    van Geldermalsen M; Wang Q; Nagarajah R; Marshall AD; Thoeng A; Gao D; Ritchie W; Feng Y; Bailey CG; Deng N; Harvey K; Beith JM; Selinger CI; O'Toole SA; Rasko JE; Holst J
    Oncogene; 2016 Jun; 35(24):3201-8. PubMed ID: 26455325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphoproteome analysis reveals differences in phosphosite profiles between tumorigenic and non-tumorigenic epithelial cells.
    Winck FV; Belloni M; Pauletti BA; Zanella Jde L; Domingues RR; Sherman NE; Paes Leme AF
    J Proteomics; 2014 Jan; 96():67-81. PubMed ID: 24211406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-Invasive Glutamine PET Reflects Pharmacological Inhibition of BRAF
    Schulte ML; Hight MR; Ayers GD; Liu Q; Shyr Y; Washington MK; Manning HC
    Mol Imaging Biol; 2017 Jun; 19(3):421-428. PubMed ID: 27770401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.